Immuno-Oncology Summit Boston 2023
07
Aug
-
09
Aug
2023
When
Boston
USA
Where

Over the past 11 years, CHI’s Immuno-Oncology Summit has become the leading annual meeting focusing on the next wave of biotherapeutics, advances in technologies, and the valuable exchange of high-quality research from all disciplines of immuno-oncology. CHI’s IO Summit provides access to a comprehensive 3-day program for participants to evaluate bi- or multi-specific biotherapeutics, explore the latest developments in existing and emerging cellular therapies, develop predictive preclinical models for translational strategies, appraise AI and computational tools for the discovery of new targets, target classes, and combinations to overcome resistance. Every year, we assemble an international mix of thought-leaders and decision-makers from industry and academia to bring you the latest developments in immuno-oncology, so that, together, we continue to align as a formidable force against cancer. Additionally, the progressive venue provides extensive networking and collaborative opportunities to enable teams to focus on their goals as they advance our understanding of the immune system to provide next-generation immunotherapies to all patients.

Similar Events

You May Like

Event

FutureCon Cybersecurity Events

0/5
(0)

At a FutureCon Conference, you’ll receive high-level cyber security training, and learn cutting-edge security approaches to manage risks in the constantly evolving world of cyber threats.

07 - 09 Aug 2023
In-Person

Speakers and Delegates
Industry Experts and Thought Leaders

SVP, Head of Clinical
Chief Scientific Officer
President, Head of Research and Development

Sponsors and Exhibitors
Brand, Media and Promotional Partners

Charles River Laboratories

At Charles River, we are passionate about our role in improving the quality of people’s lives.

Biocytogen

Biocytogen provides integrated solutions for next-generation antibody drug development to the global biomedical communities.

GenScript

Founded in 2002 and listed on the Hong Kong Stock Exchange in 2015, GenScript has an established global presence across Greater China, North America, the EU, and Asia Pacific.

Telesis Bio

Telesis Bio is empowering researchers to accelerate the creation of novel synthetic biology solutions to address some of humanity’s greatest challenges.

OmniAb, Inc.

The OmniAb discovery platform provides pharmaceutical industry partners access to diverse antibody repertoires and high-throughput screening technologies to enable discovery of next-generation therapeutics.

FUJIFILM Pharmaceuticals U.S.A., Inc.

About FUJIFILM Pharmaceuticals U.S.A., Inc.Our mission is to deliver innovative drugs to the broader population of patients worldwide at reasonable cost.FUJIFILM Pharmaceuticals U.S.A., Inc. started its operation in 2008 as FUJIFILMs global center fo

Organizer

Get emails from us

Thank you
Oops! Something went wrong